{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:39:07Z","timestamp":1787020747851,"version":"build-2736575974"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100019398","name":"Research Foundation of Beijing Friendship Hospital, Capital Medical University","doi-asserted-by":"crossref","award":["No. yyqdkt2019-19"],"award-info":[{"award-number":["No. yyqdkt2019-19"]}],"id":[{"id":"10.13039\/501100019398","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mucopolysaccharidoses are a group of lysosomal storage disorders that are caused by deficiency of enzymes involved in glycosaminoglycans degradation. Due to low prevalence and high childhood mortality, researches on mucopolysaccharidoses were mainly focused on the fatal manifestations. With the development of treatments, more and more mucopolysaccharidoses patients were treated by approved therapies, thereby getting prolonged life span and improved quality of life. Abnormal accumulation of glycosaminoglycans in the eye may block trabecular meshwork, thicken sclera and change mechanical behavior of lamina cribrosa, which, by increasing intraocular pressure and damaging optic nerve, could cause glaucoma. Glaucoma was the leading cause of irreversible blindness worldwide, but it was rarely reported in mucopolysaccharidoses patients. Although non-fatal, it seriously affected quality of life. Prevalence of glaucoma in mucopolysaccharidoses patients (ranged from 2.1 to 12.5%) indicated that glaucoma in patients with mucopolysaccharidoses was worthy of attention and further study, thereby improving the quality of life for MPSs patients.<\/jats:p>","DOI":"10.1186\/s13023-021-01935-w","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T05:03:48Z","timestamp":1626325428000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Glaucoma in mucopolysaccharidoses"],"prefix":"10.1186","volume":"16","author":[{"given":"Weijing","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxue","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2274-3249","authenticated-orcid":false,"given":"Yan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,15]]},"reference":[{"key":"1935_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8091467","author":"S Tomatsu","year":"2019","unstructured":"Tomatsu S, Pitz S, Hampel U. Ophthalmological findings in mucopolysaccharidoses. J Clin Med. 2019. https:\/\/doi.org\/10.3390\/jcm8091467.","journal-title":"J Clin Med"},{"issue":"8","key":"1935_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/diagnostics10080554","volume":"10","author":"J Wolfberg","year":"2020","unstructured":"Wolfberg J, Chintalapati K, Tomatsu S, Nagao K. hearing loss in mucopolysaccharidoses: current knowledge and future directions. Diagnostics (Basel). 2020;10(8):8. https:\/\/doi.org\/10.3390\/diagnostics10080554.","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"1935_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ymgme.2021.03.002","volume":"133","author":"EG Shapiro","year":"2021","unstructured":"Shapiro EG, Eisengart JB. The natural history of neurocognition in MPS disorders: a review. Mol Genet Metab. 2021;133(1):8\u201334. https:\/\/doi.org\/10.1016\/j.ymgme.2021.03.002.","journal-title":"Mol Genet Metab"},{"issue":"2","key":"1935_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41573-019-0049-9","volume":"19","author":"E Tambuyzer","year":"2020","unstructured":"Tambuyzer E, Vandendriessche B, Austin CP, Brooks PJ, Larsson K, Miller Needleman KI, Valentine J, Davies K, Groft SC, Preti R, et al. Therapies for rare diseases: therapeutic modalities, progress and challenges ahead. Nat Rev Drug Discov. 2020;19(2):93\u2013111. https:\/\/doi.org\/10.1038\/s41573-019-0049-9.","journal-title":"Nat Rev Drug Discov"},{"key":"1935_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21082975","author":"R Parini","year":"2020","unstructured":"Parini R, Deodato F. Intravenous Enzyme Replacement Therapy in Mucopolysaccharidoses: Clinical Effectiveness and Limitations. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21082975.","journal-title":"Int J Mol Sci"},{"issue":"Suppl 2","key":"1935_CR6","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13052-018-0564-z","volume":"44","author":"S Fecarotta","year":"2018","unstructured":"Fecarotta S, Gasperini S, Parenti G. New treatments for the mucopolysaccharidoses: from pathophysiology to therapy. Ital J Pediatr. 2018;44(Suppl 2):124. https:\/\/doi.org\/10.1186\/s13052-018-0564-z.","journal-title":"Ital J Pediatr"},{"issue":"4","key":"1935_CR7","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1136\/bjophthalmol-2017-311749","volume":"103","author":"K Sornalingam","year":"2019","unstructured":"Sornalingam K, Javed A, Aslam T, Sergouniotis P, Jones S, Ghosh A, Ashworth J. Variability in the ocular phenotype in mucopolysaccharidosis. Br J Ophthalmol. 2019;103(4):504\u201310. https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311749.","journal-title":"Br J Ophthalmol"},{"key":"1935_CR8","doi-asserted-by":"publisher","first-page":"5745","DOI":"10.2147\/IJN.S254792","volume":"15","author":"S Kwon","year":"2020","unstructured":"Kwon S, Kim SH, Khang D, Lee JY. Potential therapeutic usage of nanomedicine for glaucoma treatment. Int J Nanomed. 2020;15:5745\u201365. https:\/\/doi.org\/10.2147\/IJN.S254792.","journal-title":"Int J Nanomed"},{"issue":"18","key":"1935_CR9","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","volume":"311","author":"RN Weinreb","year":"2014","unstructured":"Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311(18):1901\u201311. https:\/\/doi.org\/10.1001\/jama.2014.3192.","journal-title":"JAMA"},{"key":"1935_CR10","doi-asserted-by":"publisher","unstructured":"Society EG: European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Chapter 3: Treatment principles and options Supported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 3 Treatment principles and options. Br J Ophthalmol 2017, 101(6):130\u2013195. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-EGSguideline.003.","DOI":"10.1136\/bjophthalmol-2016-EGSguideline.003"},{"issue":"2","key":"1935_CR11","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1111\/aos.12607","volume":"93","author":"J Ashworth","year":"2015","unstructured":"Ashworth J, Flaherty M, Pitz S, Ramlee A. Assessment and diagnosis of suspected glaucoma in patients with mucopolysaccharidosis. Acta Ophthalmol. 2015;93(2):e111-117.","journal-title":"Acta Ophthalmol"},{"key":"1935_CR12","unstructured":"Girard B, Hoang-Xuan T, D'Hermies F, Savoldelli M, Bennouna M, Poenaru L, Maroteaux P, Pouliquen Y: [Mucopolysaccharidosis type I, Hurler-Scheie phenotype with ocular involvement. Clinical and ultrastructural study]. J Fr Ophtalmol 1994, 17(4):286\u2013295"},{"issue":"9","key":"1935_CR13","doi-asserted-by":"publisher","first-page":"e259","DOI":"10.1016\/j.jfo.2016.05.012","volume":"39","author":"A Hamma","year":"2016","unstructured":"Hamma A, Bousalah M. Glaucoma and mucopolysaccharidosis type I: Report of two children. J Fr Ophtalmol. 2016;39(9):e259\u201360. https:\/\/doi.org\/10.1016\/j.jfo.2016.05.012.","journal-title":"J Fr Ophtalmol"},{"issue":"2","key":"1935_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3928\/0191-3913-19960301-13","volume":"33","author":"P Mullaney","year":"1996","unstructured":"Mullaney P, Awad AH, Millar L. Glaucoma in mucopolysaccharidosis 1-H\/S. J Pediatr Ophthalmol Strabismus. 1996;33(2):127\u201331.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"9","key":"1935_CR15","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1136\/adc.63.9.1091","volume":"63","author":"MJ Nowaczyk","year":"1988","unstructured":"Nowaczyk MJ, Clarke JT, Morin JD. Glaucoma as an early complication of Hurler\u2019s disease. Arch Dis Child. 1988;63(9):1091\u20133. https:\/\/doi.org\/10.1136\/adc.63.9.1091.","journal-title":"Arch Dis Child"},{"issue":"1","key":"1935_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0002-9394(75)90871-5","volume":"80","author":"HA Quigley","year":"1975","unstructured":"Quigley HA, Maumenee AE, Stark WJ. Acute glaucoma in systemic mucopolysaccharidosis I-S. Am J Ophthalmol. 1975;80(1):70\u20132. https:\/\/doi.org\/10.1016\/0002-9394(75)90871-5.","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"1935_CR17","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1136\/bjo.64.10.773","volume":"64","author":"E Spellacy","year":"1980","unstructured":"Spellacy E, Bankes JL, Crow J, Dourmashkin R, Shah D, Watts RW. Glaucoma in a case of Hurler disease. Br J Ophthalmol. 1980;64(10):773\u20138. https:\/\/doi.org\/10.1136\/bjo.64.10.773.","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"1935_CR18","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/bjo.74.6.382","volume":"74","author":"M Cahane","year":"1990","unstructured":"Cahane M, Treister G, Abraham FA, Melamed S. Glaucoma in siblings with Morquio syndrome. Br J Ophthalmol. 1990;74(6):382\u20133. https:\/\/doi.org\/10.1136\/bjo.74.6.382.","journal-title":"Br J Ophthalmol"},{"key":"1935_CR19","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1100\/tsw.2003.88","volume":"3","author":"KL Bergwerk","year":"2003","unstructured":"Bergwerk KL, Rabinowitz YS, Falk RE. Quality of life related to visual function in three young adults with mucopolysaccharidoses. ScientificWorldJournal. 2003;3:922\u20139. https:\/\/doi.org\/10.1100\/tsw.2003.88.","journal-title":"ScientificWorldJournal"},{"issue":"4","key":"1935_CR20","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/s0002-9394(14)73311-2","volume":"108","author":"LB Cantor","year":"1989","unstructured":"Cantor LB, Disseler JA, Wilson FM 2nd. Glaucoma in the Maroteaux-Lamy syndrome. Am J Ophthalmol. 1989;108(4):426\u201330. https:\/\/doi.org\/10.1016\/s0002-9394(14)73311-2.","journal-title":"Am J Ophthalmol"},{"key":"1935_CR21","doi-asserted-by":"crossref","unstructured":"Marinho D, Azevedo AC, Rymer S, Giugliani R, Schwartz IV: Pseudo-glaucoma in type VI mucopolysaccharidosis: case report. Arq Bras Oftalmol 2007, 70(3):563; author reply 564 doi: N\/A.","DOI":"10.1590\/S0004-27492007000300032"},{"key":"1935_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.7812\/TPP\/17-012","volume":"21","author":"M Veerappan","year":"2017","unstructured":"Veerappan M, Chak G, Shieh C, Challa P. Atypical presentation of acute angle-closure glaucoma in Maroteaux-Lamy mucopolysaccharidosis with patent prophylactic laser peripheral iridotomy: a case report. Perm J. 2017;21:17\u2013012. https:\/\/doi.org\/10.7812\/TPP\/17-012.","journal-title":"Perm J"},{"key":"1935_CR23","doi-asserted-by":"publisher","unstructured":"Sethi S, Bhartiya S, Mehta M, Chandra M, Ghose S. Hunter\u2019s syndrome and buphthalmos in a girl: an unusual ophthalmic association. Acta Ophthalmol. 2010;87:244. https:\/\/doi.org\/10.1111\/j.1755-3768.2009.2148.x.","DOI":"10.1111\/j.1755-3768.2009.2148.x"},{"issue":"1","key":"1935_CR24","first-page":"46","volume":"40","author":"SC Lin","year":"1999","unstructured":"Lin SC, Hu FR, Hou JW, Yao YT, Wang TR, Hung PT. Corneal opacity and congenital glaucoma associated with massive heparan sulfaturia: report of one case. Acta Paediatr Taiwan. 1999;40(1):46\u20139.","journal-title":"Acta Paediatr Taiwan"},{"issue":"2","key":"1935_CR25","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10545-015-9903-z","volume":"39","author":"F Sasarman","year":"2016","unstructured":"Sasarman F, Maftei C, Campeau PM, Brunel-Guitton C, Mitchell GA, Allard P. Biosynthesis of glycosaminoglycans: associated disorders and biochemical tests. J Inherit Metab Dis. 2016;39(2):173\u201388. https:\/\/doi.org\/10.1007\/s10545-015-9903-z.","journal-title":"J Inherit Metab Dis"},{"key":"1935_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21175983","author":"J Wei","year":"2020","unstructured":"Wei J, Hu M, Huang K, Lin S, Du H. Roles of proteoglycans and glycosaminoglycans in cancer development and progression. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21175983.","journal-title":"Int J Mol Sci"},{"key":"1935_CR27","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.6920","volume":"7","author":"VD Maric","year":"2019","unstructured":"Maric VD, Bozic MM, Cirkovic AM, Stankovic SD, Marjanovic IS, Grgurevic AD. Serum heparan sulfate and chondroitin sulfate concentrations in patients with newly diagnosed exfoliative glaucoma. PeerJ. 2019;7: e6920. https:\/\/doi.org\/10.7717\/peerj.6920.","journal-title":"PeerJ"},{"issue":"7","key":"1935_CR28","doi-asserted-by":"publisher","first-page":"e217","DOI":"10.1016\/j.jfo.2020.05.002","volume":"43","author":"J Buffault","year":"2020","unstructured":"Buffault J, Labbe A, Hamard P, Brignole-Baudouin F, Baudouin C. The trabecular meshwork: Structure, function and clinical implications. A review of the literature. J Fr Ophtalmol. 2020;43(7):e217\u201330. https:\/\/doi.org\/10.1016\/j.jfo.2020.05.002.","journal-title":"J Fr Ophtalmol"},{"issue":"3\u20134","key":"1935_CR29","first-page":"260","volume":"59","author":"EH Barany","year":"1954","unstructured":"Barany EH. In vitro studies of the resistance to flow through the angle of the anterior chamber. Acta Soc Med Ups. 1954;59(3\u20134):260\u201376.","journal-title":"Acta Soc Med Ups"},{"issue":"4","key":"1935_CR30","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.exer.2008.01.013","volume":"86","author":"TS Acott","year":"2008","unstructured":"Acott TS, Kelley MJ. Extracellular matrix in the trabecular meshwork. Exp Eye Res. 2008;86(4):543\u201361. https:\/\/doi.org\/10.1016\/j.exer.2008.01.013.","journal-title":"Exp Eye Res"},{"issue":"2","key":"1935_CR31","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3109\/01913123.2011.634090","volume":"36","author":"N Pescosolido","year":"2012","unstructured":"Pescosolido N, Cavallotti C, Rusciano D, Nebbioso M. Trabecular meshwork in normal and pathological eyes. Ultrastruct Pathol. 2012;36(2):102\u20137. https:\/\/doi.org\/10.3109\/01913123.2011.634090.","journal-title":"Ultrastruct Pathol"},{"issue":"12","key":"1935_CR32","first-page":"2414","volume":"37","author":"PA Knepper","year":"1996","unstructured":"Knepper PA, Goossens W, Palmberg PF. Glycosaminoglycan stratification of the juxtacanalicular tissue in normal and primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 1996;37(12):2414\u201325.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"1935_CR33","first-page":"1093","volume":"26","author":"PA Knepper","year":"1985","unstructured":"Knepper PA, Collins JA, Frederick R. Effects of dexamethasone, progesterone, and testosterone on IOP and GAGs in the rabbit eye. Invest Ophthalmol Vis Sci. 1985;26(8):1093\u2013100.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"1935_CR34","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/s1350-9462(98)00035-4","volume":"18","author":"RJ Wordinger","year":"1999","unstructured":"Wordinger RJ, Clark AF. Effects of glucocorticoids on the trabecular meshwork: towards a better understanding of glaucoma. Prog Retin Eye Res. 1999;18(5):629\u201367. https:\/\/doi.org\/10.1016\/s1350-9462(98)00035-4.","journal-title":"Prog Retin Eye Res"},{"key":"1935_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/bit.27477","author":"MJ Osmond","year":"2020","unstructured":"Osmond MJ, Krebs MD, Pantcheva MB. Human trabecular meshwork cell behavior is influenced by collagen scaffold pore architecture and glycosaminoglycan composition. Biotechnol Bioeng. 2020. https:\/\/doi.org\/10.1002\/bit.27477.","journal-title":"Biotechnol Bioeng"},{"issue":"8","key":"1935_CR36","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1136\/bjo.86.8.933","volume":"86","author":"S Sato","year":"2002","unstructured":"Sato S, Maeda N, Watanabe H, Tano Y, Inoue Y, Shimomura Y, Tanaka A. Multiple iridociliary cysts in patients with mucopolysaccharidoses. Br J Ophthalmol. 2002;86(8):933\u20134. https:\/\/doi.org\/10.1136\/bjo.86.8.933.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"1935_CR37","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/eye.2013.281","volume":"28","author":"TY Ahmed","year":"2014","unstructured":"Ahmed TY, Turnbull AM, Attridge NF, Biswas S, Lloyd IC, Au L, Ashworth JL. Anterior segment OCT imaging in mucopolysaccharidoses type I, II, and VI. Eye (Lond). 2014;28(3):327\u201336. https:\/\/doi.org\/10.1038\/eye.2013.281.","journal-title":"Eye (Lond)"},{"issue":"4","key":"1935_CR38","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1167\/iovs.11-8009","volume":"53","author":"B Coudrillier","year":"2012","unstructured":"Coudrillier B, Tian J, Alexander S, Myers KM, Quigley HA, Nguyen TD. Biomechanics of the human posterior sclera: age- and glaucoma-related changes measured using inflation testing. Invest Ophthalmol Vis Sci. 2012;53(4):1714\u201328. https:\/\/doi.org\/10.1167\/iovs.11-8009.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1935_CR39","doi-asserted-by":"publisher","DOI":"10.1098\/rsif.2016.0367","author":"BJ Murienne","year":"2016","unstructured":"Murienne BJ, Chen ML, Quigley HA, Nguyen TD. The contribution of glycosaminoglycans to the mechanical behaviour of the posterior human sclera. J R Soc Interface. 2016. https:\/\/doi.org\/10.1098\/rsif.2016.0367.","journal-title":"J R Soc Interface"},{"issue":"2","key":"1935_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227856","volume":"15","author":"H Hatami-Marbini","year":"2020","unstructured":"Hatami-Marbini H, Pachenari M. The contribution of sGAGs to stress-controlled tensile response of posterior porcine sclera. PLoS ONE. 2020;15(2): e0227856. https:\/\/doi.org\/10.1371\/journal.pone.0227856.","journal-title":"PLoS ONE"},{"key":"1935_CR41","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3389\/fcell.2020.00452","volume":"8","author":"LK Wareham","year":"2020","unstructured":"Wareham LK, Calkins DJ. The neurovascular unit in glaucomatous neurodegeneration. Front Cell Dev Biol. 2020;8:452. https:\/\/doi.org\/10.3389\/fcell.2020.00452.","journal-title":"Front Cell Dev Biol"},{"key":"1935_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2019.100773","volume":"74","author":"C Boote","year":"2020","unstructured":"Boote C, Sigal IA, Grytz R, Hua Y, Nguyen TD, Girard MJA. Scleral structure and biomechanics. Prog Retin Eye Res. 2020;74: 100773. https:\/\/doi.org\/10.1016\/j.preteyeres.2019.100773.","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"1935_CR43","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/ICU.0000000000000354","volume":"28","author":"JC Downs","year":"2017","unstructured":"Downs JC, Girkin CA. Lamina cribrosa in glaucoma. Curr Opin Ophthalmol. 2017;28(2):113\u20139. https:\/\/doi.org\/10.1097\/ICU.0000000000000354.","journal-title":"Curr Opin Ophthalmol"},{"issue":"7","key":"1935_CR44","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1167\/iovs.18-23845","volume":"59","author":"DE Midgett","year":"2018","unstructured":"Midgett DE, Jefferys JL, Quigley HA, Nguyen TD. The contribution of sulfated glycosaminoglycans to the inflation response of the human optic nerve head. Invest Ophthalmol Vis Sci. 2018;59(7):3144\u201354. https:\/\/doi.org\/10.1167\/iovs.18-23845.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"1935_CR45","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1001\/archopht.117.7.917","volume":"117","author":"G Tezel","year":"1999","unstructured":"Tezel G, Edward DP, Wax MB. Serum autoantibodies to optic nerve head glycosaminoglycans in patients with glaucoma. Arch Ophthalmology (Chicago, III: 1960). 1999;117(7):917\u201324. https:\/\/doi.org\/10.1001\/archopht.117.7.917.","journal-title":"Arch Ophthalmology (Chicago, III: 1960)"},{"issue":"2","key":"1935_CR46","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2174\/1874609811104020110","volume":"4","author":"G Guedes","year":"2011","unstructured":"Guedes G, Tsai JC, Loewen NA. Glaucoma and aging. Curr Aging Sci. 2011;4(2):110\u20137. https:\/\/doi.org\/10.2174\/1874609811104020110.","journal-title":"Curr Aging Sci"},{"issue":"Suppl 2","key":"1935_CR47","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13052-018-0551-4","volume":"44","author":"M Rigoldi","year":"2018","unstructured":"Rigoldi M, Verrecchia E, Manna R, Mascia MT. Clinical hints to diagnosis of attenuated forms of Mucopolysaccharidoses. Ital J Pediatr. 2018;44(Suppl 2):132. https:\/\/doi.org\/10.1186\/s13052-018-0551-4.","journal-title":"Ital J Pediatr"},{"issue":"6","key":"1935_CR48","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1515\/jpem-2019-0505","volume":"33","author":"W Kong","year":"2020","unstructured":"Kong W, Meng Y, Zou L, Yang G, Wang J, Shi X. Mucopolysaccharidosis III in Mainland China: natural history, clinical and molecular characteristics of 34 patients. J Pediatr Endocrinol Metab. 2020;33(6):793\u2013802. https:\/\/doi.org\/10.1515\/jpem-2019-0505.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"1935_CR49","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ymgme.2014.12.001","volume":"114","author":"S Tomatsu","year":"2015","unstructured":"Tomatsu S, Almeciga-Diaz CJ, Montano AM, Yabe H, Tanaka A, Dung VC, Giugliani R, Kubaski F, Mason RW, Yasuda E, et al. Therapies for the bone in mucopolysaccharidoses. Mol Genet Metab. 2015;114(2):94\u2013109. https:\/\/doi.org\/10.1016\/j.ymgme.2014.12.001.","journal-title":"Mol Genet Metab"},{"issue":"Suppl 2","key":"1935_CR50","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13052-018-0559-9","volume":"44","author":"A Del Longo","year":"2018","unstructured":"Del Longo A, Piozzi E, Schweizer F. Ocular features in mucopolysaccharidosis: diagnosis and treatment. Ital J Pediatr. 2018;44(Suppl 2):125. https:\/\/doi.org\/10.1186\/s13052-018-0559-9.","journal-title":"Ital J Pediatr"},{"issue":"10","key":"1935_CR51","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/gim.2014.25","volume":"16","author":"M Beck","year":"2014","unstructured":"Beck M, Arn P, Giugliani R, Muenzer J, Okuyama T, Taylor J, Fallet S. The natural history of MPS I: global perspectives from the MPS I Registry. Genet Med. 2014;16(10):759\u201365. https:\/\/doi.org\/10.1038\/gim.2014.25.","journal-title":"Genet Med"},{"issue":"5","key":"1935_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.617","volume":"7","author":"HY Lin","year":"2019","unstructured":"Lin HY, Chan WC, Chen LJ, Lee YC, Yeh SI, Niu DM, Chiu PC, Tsai WH, Hwu WL, Chuang CK, et al. Ophthalmologic manifestations in Taiwanese patients with mucopolysaccharidoses. Mol Genet Genomic Med. 2019;7(5): e00617. https:\/\/doi.org\/10.1002\/mgg3.617.","journal-title":"Mol Genet Genomic Med"},{"issue":"1","key":"1935_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168698","volume":"12","author":"J Wasielica-Poslednik","year":"2017","unstructured":"Wasielica-Poslednik J, Politino G, Schmidtmann I, Lorenz K, Bell K, Pfeiffer N, Pitz S. Influence of corneal opacity on intraocular pressure assessment in patients with lysosomal storage diseases. PLoS ONE. 2017;12(1): e0168698. https:\/\/doi.org\/10.1371\/journal.pone.0168698.","journal-title":"PLoS ONE"},{"issue":"8","key":"1935_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133586","volume":"10","author":"J Wasielica-Poslednik","year":"2015","unstructured":"Wasielica-Poslednik J, Butsch C, Lampe C, Elflein H, Lamparter J, Weyer V, Pitz S. Comparison of rebound tonometry, perkins applanation tonometry and ocular response analyser in mucopolysaccharidosis patients. PLoS ONE. 2015;10(8): e0133586. https:\/\/doi.org\/10.1371\/journal.pone.0133586.","journal-title":"PLoS ONE"},{"issue":"1","key":"1935_CR55","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12886-019-1288-6","volume":"20","author":"H Zhang","year":"2020","unstructured":"Zhang H, Sun Z, Li L, Sun R, Zhang H. Comparison of intraocular pressure measured by ocular response analyzer and Goldmann applanation tonometer after corneal refractive surgery: a systematic review and meta-analysis. BMC Ophthalmol. 2020;20(1):23. https:\/\/doi.org\/10.1186\/s12886-019-1288-6.","journal-title":"BMC Ophthalmol"},{"issue":"8","key":"1935_CR56","doi-asserted-by":"publisher","first-page":"e676","DOI":"10.1111\/aos.13098","volume":"94","author":"A Javed","year":"2016","unstructured":"Javed A, Aslam T, Ashworth J. Use of new imaging in detecting and monitoring ocular manifestations of the mucopolysaccharidoses. Acta Ophthalmol. 2016;94(8):e676\u201382. https:\/\/doi.org\/10.1111\/aos.13098.","journal-title":"Acta Ophthalmol"},{"issue":"7","key":"1935_CR57","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/j.1755-3768.2011.02280.x","volume":"90","author":"KT Fahnehjelm","year":"2012","unstructured":"Fahnehjelm KT, Ashworth JL, Pitz S, Olsson M, Tornquist AL, Lindahl P, Summers CG. Clinical guidelines for diagnosing and managing ocular manifestations in children with mucopolysaccharidosis. Acta Ophthalmol. 2012;90(7):595\u2013602. https:\/\/doi.org\/10.1111\/j.1755-3768.2011.02280.x.","journal-title":"Acta Ophthalmol"},{"key":"1935_CR58","doi-asserted-by":"publisher","unstructured":"Blanco AA, Bagnasco L, Bagnis A, Barton K, Baudouin C, Bengtsson B, Bron A, Cordeiro F: European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Part 1Supported by the EGS Foundation. Br J Ophthalmol 2017. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-EGSguideline.001.","DOI":"10.1136\/bjophthalmol-2016-EGSguideline.001"},{"key":"1935_CR59","doi-asserted-by":"publisher","unstructured":"Blanco AA, Bagnasco L, Bagnis A, Barton K, Baudouin C, Bengtsson B, Bron A, Cordeiro F: European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Chapter 2: Classification and terminologySupported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 2 Classification and Terminology. Br J Ophthalmol 2017, 101(5):73\u2013127. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-EGSguideline.002.","DOI":"10.1136\/bjophthalmol-2016-EGSguideline.002"},{"key":"1935_CR60","doi-asserted-by":"publisher","unstructured":"Blanco AA, Bagnasco L, Bagnis A, Barton K, Baudouin C, Bengtsson B, Bron A, Cordeiro F: European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Chapter 3: Treatment principles and options Supported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 3 Treatment principles and options. Br J Ophthalmol 2017, 101(6):130\u2013195. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-EGSguideline.003.","DOI":"10.1136\/bjophthalmol-2016-EGSguideline.003"},{"issue":"13","key":"1935_CR61","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1182\/blood-2014-11-608075","volume":"125","author":"M Aldenhoven","year":"2015","unstructured":"Aldenhoven M, Wynn RF, Orchard PJ, O\u2019Meara A, Veys P, Fischer A, Valayannopoulos V, Neven B, Rovelli A, Prasad VK, et al. Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study. Blood. 2015;125(13):2164\u201372. https:\/\/doi.org\/10.1182\/blood-2014-11-608075.","journal-title":"Blood"},{"issue":"1 (Supplment s1","key":"1935_CR62","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1442-9071.2010.02366.x","volume":"38","author":"CG Summers","year":"2010","unstructured":"Summers CG, Fahnehjelm KT, Pitz S, Guffon N, Koseoglu ST, Harmatz P, Scarpa M. Systemic therapies for mucopolysaccharidosis: Ocular changes following haematopoietic stem cell transplantation or enzyme replacement therapy - a review. Clinic Exp Ophthalmol. 2010;38(1 (Supplment s1)):34\u201342. https:\/\/doi.org\/10.1111\/j.1442-9071.2010.02366.x.","journal-title":"Clinic Exp Ophthalmol"},{"issue":"10","key":"1935_CR63","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1001\/archopht.125.10.1353","volume":"125","author":"S Pitz","year":"2007","unstructured":"Pitz S, Ogun O, Bajbouj M, Arash L, Schulze-Frenking G, Beck M. Ocular changes in patients with mucopolysaccharidosis I receiving enzyme replacement therapy: a 4-year experience. Arch Ophthalmol (Chicago, III: 1960). 2007;125(10):1353\u20136. https:\/\/doi.org\/10.1001\/archopht.125.10.1353.","journal-title":"Arch Ophthalmol (Chicago, III: 1960)"},{"issue":"3","key":"1935_CR64","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1056\/NEJM200101183440304","volume":"344","author":"ED Kakkis","year":"2001","unstructured":"Kakkis ED, Muenzer J, Tiller GE, Waber L, Belmont J, Passage M, Izykowski B, Phillips J, Doroshow R, Walot I, et al. Enzyme-replacement therapy in mucopolysaccharidosis I. N Engl J Med. 2001;344(3):182\u20138. https:\/\/doi.org\/10.1056\/NEJM200101183440304.","journal-title":"N Engl J Med"},{"issue":"10","key":"1935_CR65","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s00431-008-0910-z","volume":"168","author":"M Scarpa","year":"2009","unstructured":"Scarpa M, Barone R, Fiumara A, Astarita L, Parenti G, Rampazzo A, Sala S, Sorge G, Parini R. Mucopolysaccharidosis VI: the Italian experience. Eur J Pediatr. 2009;168(10):1203\u20136. https:\/\/doi.org\/10.1007\/s00431-008-0910-z.","journal-title":"Eur J Pediatr"},{"issue":"5","key":"1935_CR66","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00247-008-0788-y","volume":"38","author":"RG Schumacher","year":"2008","unstructured":"Schumacher RG, Brzezinska R, Schulze-Frenking G, Pitz S. Sonographic ocular findings in patients with mucopolysaccharidoses I, II and VI. Pediatric Radiol. 2008;38(5):543\u201350. https:\/\/doi.org\/10.1007\/s00247-008-0788-y.","journal-title":"Pediatric Radiol"},{"issue":"3","key":"1935_CR67","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4103\/tjo.tjo_85_17","volume":"9","author":"HY Lin","year":"2019","unstructured":"Lin HY, Huang YH, Lei SY, Chen LJ, Lin SP. Clinical ocular manifestations of Taiwanese patients with mucopolysaccharidoses VI (Maroteaux-Lamy syndrome). Taiwan J Ophthalmol. 2019;9(3):194\u20137. https:\/\/doi.org\/10.4103\/tjo.tjo_85_17.","journal-title":"Taiwan J Ophthalmol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01935-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-01935-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01935-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T05:11:00Z","timestamp":1626325860000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-01935-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,15]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1935"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-01935-w","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,15]]},"assertion":[{"value":"5 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"312"}}